Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients

Luigi Ballerini; Franco Barbaresi; Giovanni Binaghi; Carmelo Cernigliaro; Raffaello Chioin; Luigi Inglese; Giorgio Invernizzi; Susanna Leto di Priolo; Eustaquio Onorato; Federico Passoni; Giuseppe Richichi; Umberto Squarcia; Roberte Violini

doi:10.1007/BF01137565

Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients

Luigi Ballerini, Franco Barbaresi, Giovanni Binaghi, Carmelo Cernigliaro, Raffaello Chioin, Luigi Inglese, Giorgio Invernizzi, Susanna Leto di Priolo, Eustaquio Onorato, Federico Passoni, Giuseppe Richichi, Umberto Squarcia, Roberte Violini

IRCCS Policlinico San Donato

Research output: Contribution to journal › Article › peer-review

Abstract

To evaluate the complication rate in paediatric cardioangiography with the nonionic contrast medium iopamidol data on 8,166 procedures were retrospectively collected in 12 centres. The overall complication rate was 3.78% (309/8,166), 3.44% were related to the procedure, and 0.34% to the contrast medium. The mortality rate varied with age. It was higher in patients <2 months (0.38%) than in patients >2 months-2 years (0.06%) and in patients older than 2 years (0.03%). The total complication rate was higher than the one observed in a similar retrospective analysis performed in adult patients (1.89%). This difference is probably due to higher risk conditions of the younger patients. However the contrast medium related complication rate (0.34% vs 0.4%) and the mortality rate (0.11% vs 0.1%) were comparable, confirming the good tolerability of iopamidol in cardiac catheterisation also in paediatric patients.

Original language	English
Pages (from-to)	45-52
Number of pages	8
Journal	The International Journal of Cardiac Imaging
Volume	8
Issue number	1
DOIs	https://doi.org/10.1007/BF01137565
Publication status	Published - Mar 1992

Keywords

cardiac catheterisation
complications
iopamidol
paediatrics

ASJC Scopus subject areas

Radiological and Ultrasound Technology
Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

Access to Document

10.1007/BF01137565

Cite this

Ballerini, L., Barbaresi, F., Binaghi, G., Cernigliaro, C., Chioin, R., Inglese, L., Invernizzi, G., di Priolo, S. L., Onorato, E., Passoni, F., Richichi, G., Squarcia, U., & Violini, R. (1992). Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients. The International Journal of Cardiac Imaging, 8(1), 45-52. https://doi.org/10.1007/BF01137565

Ballerini, L, Barbaresi, F, Binaghi, G, Cernigliaro, C, Chioin, R, Inglese, L, Invernizzi, G, di Priolo, SL, Onorato, E, Passoni, F, Richichi, G, Squarcia, U & Violini, R 1992, 'Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients', The International Journal of Cardiac Imaging, vol. 8, no. 1, pp. 45-52. https://doi.org/10.1007/BF01137565

@article{7a92c02acc0b42fb96f3f6984cb42bd3,

title = "Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients",

abstract = "To evaluate the complication rate in paediatric cardioangiography with the nonionic contrast medium iopamidol data on 8,166 procedures were retrospectively collected in 12 centres. The overall complication rate was 3.78% (309/8,166), 3.44% were related to the procedure, and 0.34% to the contrast medium. The mortality rate varied with age. It was higher in patients <2 months (0.38%) than in patients >2 months-2 years (0.06%) and in patients older than 2 years (0.03%). The total complication rate was higher than the one observed in a similar retrospective analysis performed in adult patients (1.89%). This difference is probably due to higher risk conditions of the younger patients. However the contrast medium related complication rate (0.34% vs 0.4%) and the mortality rate (0.11% vs 0.1%) were comparable, confirming the good tolerability of iopamidol in cardiac catheterisation also in paediatric patients.",

keywords = "cardiac catheterisation, complications, iopamidol, paediatrics",

author = "Luigi Ballerini and Franco Barbaresi and Giovanni Binaghi and Carmelo Cernigliaro and Raffaello Chioin and Luigi Inglese and Giorgio Invernizzi and {di Priolo}, {Susanna Leto} and Eustaquio Onorato and Federico Passoni and Giuseppe Richichi and Umberto Squarcia and Roberte Violini",

year = "1992",

month = mar,

doi = "10.1007/BF01137565",

language = "English",

volume = "8",

pages = "45--52",

journal = "International Journal of Cardiovascular Imaging",

issn = "1569-5794",

publisher = "Springer Netherlands",

number = "1",

}

TY - JOUR

T1 - Iopamidol in cardioangiography

T2 - a retrospective, multicentre study - Part II. Paediatric patients

AU - Ballerini, Luigi

AU - Barbaresi, Franco

AU - Binaghi, Giovanni

AU - Cernigliaro, Carmelo

AU - Chioin, Raffaello

AU - Inglese, Luigi

AU - Invernizzi, Giorgio

AU - di Priolo, Susanna Leto

AU - Onorato, Eustaquio

AU - Passoni, Federico

AU - Richichi, Giuseppe

AU - Squarcia, Umberto

AU - Violini, Roberte

PY - 1992/3

Y1 - 1992/3

N2 - To evaluate the complication rate in paediatric cardioangiography with the nonionic contrast medium iopamidol data on 8,166 procedures were retrospectively collected in 12 centres. The overall complication rate was 3.78% (309/8,166), 3.44% were related to the procedure, and 0.34% to the contrast medium. The mortality rate varied with age. It was higher in patients <2 months (0.38%) than in patients >2 months-2 years (0.06%) and in patients older than 2 years (0.03%). The total complication rate was higher than the one observed in a similar retrospective analysis performed in adult patients (1.89%). This difference is probably due to higher risk conditions of the younger patients. However the contrast medium related complication rate (0.34% vs 0.4%) and the mortality rate (0.11% vs 0.1%) were comparable, confirming the good tolerability of iopamidol in cardiac catheterisation also in paediatric patients.

AB - To evaluate the complication rate in paediatric cardioangiography with the nonionic contrast medium iopamidol data on 8,166 procedures were retrospectively collected in 12 centres. The overall complication rate was 3.78% (309/8,166), 3.44% were related to the procedure, and 0.34% to the contrast medium. The mortality rate varied with age. It was higher in patients <2 months (0.38%) than in patients >2 months-2 years (0.06%) and in patients older than 2 years (0.03%). The total complication rate was higher than the one observed in a similar retrospective analysis performed in adult patients (1.89%). This difference is probably due to higher risk conditions of the younger patients. However the contrast medium related complication rate (0.34% vs 0.4%) and the mortality rate (0.11% vs 0.1%) were comparable, confirming the good tolerability of iopamidol in cardiac catheterisation also in paediatric patients.

KW - cardiac catheterisation

KW - complications

KW - iopamidol

KW - paediatrics

UR - http://www.scopus.com/inward/record.url?scp=0026650532&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026650532&partnerID=8YFLogxK

U2 - 10.1007/BF01137565

DO - 10.1007/BF01137565

M3 - Article

C2 - 1619304

AN - SCOPUS:0026650532

VL - 8

SP - 45

EP - 52

JO - International Journal of Cardiovascular Imaging

JF - International Journal of Cardiovascular Imaging

SN - 1569-5794

IS - 1

ER -

Iopamidol in cardioangiography: a retrospective, multicentre study - Part II. Paediatric patients

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this